Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
This study is ongoing, but not recruiting participants.
Study NCT00005612 Information provided by National Cancer Institute (NCI)
First Received: May 2, 2000 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ovarian Cancer
Additional conditions recognized in this trial
Neoplasm, Residual
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Neoplasms
Neoplasms by Site
Neoplastic Processes
Ovarian Diseases
Pathologic Processes
Urogenital Neoplasms
Interventions listed in this trial
filgrastim
carboplatin
cyclophosphamide
etoposide
paclitaxel
topotecan hydrochloride
Additional drug interventions recognized in this trial
Etoposide phosphate
Topotecan
More general drug interventions related to this trial
Alkylating Agents
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Back to top of Main Content
